Archives

by in
Entry Author Date Location
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News 06/23/11 Seattle
Cyterix Develops New Twist on an Old Idea, With ‘Smart Bomb’ Cancer Drugs 06/22/11 San Francisco
SeaGen Promotes Dobmeier 06/17/11 Seattle
ASCO Wrap-Up, Pathway Medical Grinds It Out, Gates Foundation’s New Digs, & More in Seattle-Area Life Sciences News 06/09/11 Seattle
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S. 06/07/11 National
Resolve Maps Out New Biotech Model, SeaGen Expands, Schadt Heads East, & More in Seattle-Area Life Sciences News 05/19/11 Seattle
SeaGen Adds $7.7M Lease 05/13/11 Seattle
Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News 05/12/11 Seattle
Why Are Drugs Getting Such Weird Brand Names? 05/09/11 National
SeaGen Ends March With $456M Cash 05/05/11 Seattle
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News 05/05/11 Seattle
SeaGen FDA Deadline Set for Aug. 30 05/02/11 Seattle
Life Science Discovery Fund Faces Cuts, Boeing’s Biofuel Push, SeaGen’s Latest Deal, & More Seattle-Area Life Sciences News 04/21/11 Seattle
Genmab Expands SeaGen Alliance 04/19/11 Seattle
SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News 03/24/11 Seattle
SeaGen Inks Abbott Deal 03/22/11 Seattle
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
SeaGen Expands Millennium Deal 03/15/11 Seattle
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised 03/14/11 National
Dendreon Moves Across Town, SeaGen Files FDA App, Alder Takes Road Less Traveled, & More Seattle Life Sciences News 03/03/11 Seattle
SeaGen Turns in FDA Application 02/28/11 Seattle
Dendreon Adds $80M, Amgen Advances ‘Son of Dmab,’ Mobisante Wins FDA OK, & More Seattle-Area Life Sciences News 02/10/11 Seattle
SeaGen Expects $280M Cash at Year End 02/08/11 Seattle
SeaGen Tacks on $23M 02/03/11 Seattle
Seattle Genetics Reloads, Uptake Ups and Leaves, PhysioSonics Raises Cash, & More Seattle-Area Life Sciences News 02/03/11 Seattle
Seattle Genetics Reloads Cash Reserves With $155M, On Cusp of Selling First Drug 02/02/11 Seattle
Seattle Genetics Manager Accused of Insider Trading, Bristol Stays in Seattle, Amgen Buys BioVex, & More Seattle-Area Life Sciences News 01/27/11 Seattle
SEC Accuses Seattle Genetics Employee of Insider Trading 01/21/11 Seattle
The State of Seattle Biotech 2011: Xconomy’s Chat With UW Faculty & Students 01/19/11 Seattle
Page 3 of 8 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.